ClinicalTrials.gg
CompletedNCT07332806Updated Oct 21, 2026

Site of Tracheal Extubation and Operating Room Efficiency During Robot-assisted Surgery

An interventional study of Extubation in post-anesthesia care unit (PACU) and Extubation in operating room (OR) in Robotic Surgical Procedures, Airway Extubation and Operating Rooms, sponsored by Peking University First Hospital. Completed at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by Peking University First Hospital · Not applicable, Interventional, and Treatment

How we know

Updated Oct 21, 2026Now CompletedStart date moved+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
218
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 18 studies in Postoperative Complications by Peking University First Hospital — 3 open to participants now, 3 under way, none of them phase 3. Postoperative Complications · Peking University First Hospital.

Enrollment
11th of 14
218 · median 864
Started
2026
with 1 other
No phase
7 of 18
1 open now
Registered
17th of 18
by date

Among the 18 studies in Postoperative Complications by Peking University First Hospital, this one is the 11th largest by enrollment of the 14 interventional ones that give a count, is one of 2 that started in 2026, is one of 7 with no phase, and was the 17th registered.

Postoperative Complications

1,343 studies on the registry are indexed under Postoperative Complications; 314 are open to participants now.

Browse Postoperative Complications studies →

Open to participants now

3 of the 18 studies in Postoperative Complications by Peking University First Hospital are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 200 Postoperative Complications studies recruiting now, 126 (63%) set no upper age limit and 31 (16%) stop at 75 or younger; 24 take children under 18; 25 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies in Postoperative Complications by Peking University First Hospital, or all of them as a file.
02

Study summary

This study aims to evaluate the impact of different extubation strategy on the occupancy time of operating room (OR) and the incidence of adverse events and quality of recovery after robotic-assisted surgery. The investigators hypothesize that extubation in the post-anesthesia care unit (PACU) may reduce OR occupancy time without increasing adverse events or worsening quality of recovery early after robotic-assisted surgery. This strategy may enhance perioperative efficiency while maintaining clinical safety.

Read the detailed description

Major surgeries are generally performed under general anesthesia with endotracheal tube. Intubation during anesthesia induction and extubation during anesthesia emergence are two high-risk periods associated with anesthesia-related complications. In clinical practice, extubation is performed either in the OR or in the PACU, according to local routine.

Robotic-assisted surgery offers potential clinical benefits but involves high costs and limited resource availability, making operating room (OR) efficiency a critical priority. While extubation in the post-anesthesia care unit (PACU) has been suggested to improve OR turnover, evidence regarding its impact on perioperative efficiency and safety compared to standard OR extubation in robotic surgery is limited.

The investigators hypothesize that extubation in the post-anesthesia care unit (PACU) may reduce OR occupancy time without increasing adverse events or worsening quality of recovery early after robotic-assisted surgery. This study aims to evaluate the impact of different extubation strategy on the occupancy time of operating room (OR) and the incidence of adverse events and quality of recovery after robotic-assisted surgery.

03

Conditions studied

  • Robotic Surgical Procedures
  • Airway Extubation
  • Operating Rooms
  • Anesthesia Recovery Period
  • Postoperative Complications

Keywords

  • Robotic Surgical Procedures
  • Airway Extubation
  • Operating Rooms
  • Anesthesia Recovery Period
  • Postoperative Complications
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Aged ≥18 years;
  2. Scheduled to undergo elective robot-assisted laparoscopic surgery under general anesthesia;
  3. Expected tracheal extubation during daytime working hours (before 4:00 PM).

Exclusion criteria

Exclusion Criteria:

  1. Refuse to participate in the study;
  2. Morbid obesity ( ≥35 kg/m²);
  3. Preoperatively diagnosed obstructive sleep apnea, or patients with a STOP-Bang score ≥3 in combination with serum bicarbonate (HCO₃-) ≥28 mmol/L;
  4. Patients at high risk of difficult airway (anticipated difficult intubation and/or extubation during preoperative assessment);
  5. Preexisting sick sinus syndrome, severe sinus bradycardia (heart rate \< 50 beats/min), or second-degree or higher atrioventricular block without pacemaker implantation; congenital heart disease with any type of arrhythmia; or other severe cardiovascular diseases with (NYHA) functional class ≥III;
  6. Significant pulmonary function impairment (/FVC ratio \< 70%, and total lung capacity [TLC] and vital capacity [VC] \< 80% of predicted values);
  7. Severe hepatic dysfunction ( class C); severe renal dysfunction (estimated \< 30 mL/min/1.73 m²); or (ASA) physical status classification ≥IV;
  8. Preoperative diagnoses of schizophrenia, epilepsy, Parkinson's disease, or myasthenia gravis;
  9. Inability to communicate due to coma, severe dementia, or language impairment;
  10. Planned postoperative admission to the intensive care unit;
  11. Any other conditions that are deemed for study participation.
Terms in these criteria, in plain language(6)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

NYHA class (heart failure)

The New York Heart Association’s four classes of how much heart failure limits physical activity.

I
No limits: ordinary activity causes no undue tiredness or breathlessness.
II
Slight limits: comfortable at rest, ordinary activity causes symptoms.
III
Marked limits: comfortable at rest, less than ordinary activity causes symptoms.
IV
Symptoms even at rest; any activity makes them worse.

Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.

FEV1

From a breathing test (spirometry): how much air you can blow out in the first second. Often given as a percentage of what is expected for your age, height and sex.

Child-Pugh class

A score of how well the liver works in people with liver disease such as cirrhosis: class A is mild, B moderate and C severe.

GFR and eGFR (kidney filtering)

GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².

Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
218 participants (actual)

Study arms

  • Experimental
    Extubation in post-anesthesia care unit (PACU)

    At the end of surgery, patients will be transferred from operating room (OR) to PACU with endotracheal intubation and then extubated in PACU.

    Procedure: Extubation in post-anesthesia care unit (PACU)

  • Active comparator
    Extubation in operating room (OR)

    At the end of surgery, patients will be extubated in operating room (OR) and then transfered to PACU.

    Procedure: Extubation in operating room (OR)

Interventions

  • ProcedureExtubation in post-anesthesia care unit (PACU)

    At the end of surgery, patients will be transfered from OR to PACU with endotracheal intubation and then extubated in PACU.

    Also known as: PACU extubation

  • ProcedureExtubation in operating room (OR)

    At the end of surgery, patients will be extubated in OR and then transfered from OR to PACU.

    Also known as: OR extubation

06

What researchers measure

Primary outcomes

  1. Operating room (OR) occupancy time

    Time interval from end of surgery to leaving OR for PACU.

    Time frame: Up to 2 hours after surgery

Secondary outcomes

  1. Incidence of emergence delirium

    Emergence delirium will be assessed with the confusion assessment method for the intensive care unit (CAM-ICU).

    Time frame: Up to 3 hours after surgery

  2. Incidence of adverse events before leaving PACU

    An adverse event indicates any unpredictable, unfavourable medical event that is associated with any medical intervention and occurs from end of surgery to the timepoint of leaving PACU.

    Time frame: Up to 3 hours after surgery

  3. Time interval from end of surgery to modified Aldrete score of ≥9

    Modified Aldrete Score is used to assess post-anesthesia recovery in five aspects (activity, respiration, circulation, consciousness, and oxygenation); scores range from 0 to 10, with higher scores indicating better recovery. A score of ≥9 indicates that patients can be safely transferred from PACU to general wards.

    Time frame: Up to 3 hours after surgery

  4. Time interval from end of surgery to PACU discharge

    Time interval from end of surgery to PACU discharge.

    Time frame: Up to 2 hours after surgery

Other outcomes

  1. Time interval from end of surgery to extubation

    Time interval from end of surgery to extubation.

    Time frame: Up to 3 hours after surgery

  2. Turnover time in the operating room

    Time interval between leaving OR of the last patient and entering OR of the next patient.

    Time frame: Up to 3 hours after surgery

  3. Ready for surgery time in the operating room

    Time interval between end of surgry of the last patient and ready for surgery of the next patient.

    Time frame: Up to 3 hours after surgery

  4. Quality of recovery on postoperative day 1

    Quality of recovery (QoR) will be assessed using the QoR-15. QoR-15 is a 15-item scale that assesses quality of postoperative recovery in 5 domains including pain, physical comfort, physiological independence, psychological state, and support and communication. Scores range from 0 to 150, with higher scores indicating better recovery.

    Time frame: At 24 hours after surgery

  5. Length of hospital stay (LOS) after surgery

    Length of hospital stay (LOS) after surgery.

    Time frame: Up to 30 days after surgery

  6. 30-day all-cause mortality

    30-day all-cause mortality

    Time frame: Up to 30 days after surgery

  7. Incidence of postoperative complications within 30 days

    Postoperative complications indicate any new-onset medical events that are deemed harmful and require therateutic intervention, i.e., grade 2 or higher on the Clavien-Dindo classification (grades range from I to V, with higher grade indicating more severe complications).

    Time frame: Up to 30 days after surgery

  8. Total costs during hospitalization

    Total costs during hospitalization

    Time frame: Up to 30 days after surgery.

07

Study locations

1 site
  • Peking University Fist Hospital
    Beijing, Beijing Municipality 100034, China
08

References and documents

Publications

  • Godet T, Wajew C, Fabrizi M, Monet C, Pouzeratte Y, Lapeyre M, Adelou S, Pereira B, Garnier M, Chanques G, Jabaudon M, Futier E, Jaber S, De Jong A. Impact of tracheal extubation location after surgical procedures on peri-operative times: a prospective dual-centre observational study. Anaesthesia. 2025 Aug;80(8):915-926. doi: 10.1111/anae.16620. Epub 2025 May 12. PubMed 40351134 ↗
  • Langeron O, Bourgain JL, Francon D, Amour J, Baillard C, Bouroche G, Chollet Rivier M, Lenfant F, Plaud B, Schoettker P, Fletcher D, Velly L, Nouette-Gaulain K. Difficult intubation and extubation in adult anaesthesia. Anaesth Crit Care Pain Med. 2018 Dec;37(6):639-651. doi: 10.1016/j.accpm.2018.03.013. Epub 2018 May 23. PubMed 29802903 ↗
  • Thilen SR, Weigel WA, Todd MM, Dutton RP, Lien CA, Grant SA, Szokol JW, Eriksson LI, Yaster M, Grant MD, Agarkar M, Marbella AM, Blanck JF, Domino KB. 2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade: A Report by the American Society of Anesthesiologists Task Force on Neuromuscular Blockade. Anesthesiology. 2023 Jan 1;138(1):13-41. doi: 10.1097/ALN.0000000000004379. PubMed 36520073 ↗
  • Apfelbaum JL, Hagberg CA, Connis RT, Abdelmalak BB, Agarkar M, Dutton RP, Fiadjoe JE, Greif R, Klock PA, Mercier D, Myatra SN, O'Sullivan EP, Rosenblatt WH, Sorbello M, Tung A. 2022 American Society of Anesthesiologists Practice Guidelines for Management of the Difficult Airway. Anesthesiology. 2022 Jan 1;136(1):31-81. doi: 10.1097/ALN.0000000000004002. PubMed 34762729 ↗
  • Banik RK, Honeyfield K, Qureshi S, Reddy SG. Incidence and Mortality Rate of Perioperative Reintubation: Case Series of 196 Patients. AANA J. 2021 Dec;89(6):476-479. PubMed 34809752 ↗
  • Chen S, Zhang Y, Che L, Shen L, Huang Y. Risk factors for unplanned reintubation caused by acute airway compromise after general anesthesia: a case-control study. BMC Anesthesiol. 2021 Jan 12;21(1):17. doi: 10.1186/s12871-021-01238-4. PubMed 33435881 ↗
  • Koga K, Asai T, Vaughan RS, Latto IP. Respiratory complications associated with tracheal extubation. Timing of tracheal extubation and use of the laryngeal mask during emergence from anaesthesia. Anaesthesia. 1998 Jun;53(6):540-4. doi: 10.1046/j.1365-2044.1998.00397.x. PubMed 9709138 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2026 to primary completion in Aug 2026, 6 months.

Of 395 non-industry interventional studies with no phase under Postoperative Complications, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 44. This study's 6 months is below that.

Counting every sponsor, half of 399 studies reached it within 20 months; a quarter within 8 and three quarters within 44.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 21, 2026: primary completion Apr 2026 → Aug 2026 and completion Apr 2026 → Sep 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Dec 15, 2025
First posted
Jan 12, 2026
StartActual
Jan 24, 2026
Primary completionActual
Aug 19, 2026was Apr 2026
CompletionActual
Sep 19, 2026was Apr 2026
Last update
Oct 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Oct 21, 2026
Start date
Jan 12, 2026→Jan 24, 2026
Oct 21, 2026
Primary completion
Apr 2026→Aug 19, 2026 (actual)
Oct 21, 2026
Study completion
Apr 2026→Sep 19, 2026 (actual)
Oct 21, 2026
Show all 1 update
  1. Oct 21, 2026
    Recruiting→Completed
    Start date Jan 12, 2026→Jan 24, 2026
    Primary completion Apr 2026→Aug 19, 2026 (now actual)
    Study completion Apr 2026→Sep 19, 2026 (now actual)
    + 3 other changes: verification date, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07332806
Responsible party
Dong-Xin Wang (Chief Physician, Professor, Peking University First Hospital) — Principal investigator
First posted
Jan 12, 2026
Start date
Jan 24, 2026
Primary completion
Aug 19, 2026
Completion
Sep 19, 2026
Last update
Oct 21, 2026

Study contacts

Dong-Xin Wang, MD, PhD
principal investigator · Peking University First Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion